Today’s article highlights two clinical-stage biotech stocks that analysts believe are not only likely to be winners this year, but that have the potential to… Read More »These 2 Biotech Stocks Could Double – Or More – This Year
No matter how pricey the market may be (and most would agree the market is pretty pricey right now), there is always some value to… Read More »“Too Cheap To Ignore”: 3 Stocks That Could Be Great Value Investments In This Pricey Market
Be it value, growth, momentum, size, low volatility, some blend thereof – or something else entirely, factor investment strategies have been gaining popularity. In fact,… Read More »“Hooked”: Are Some Investors Addicted To The “Cheap Highs” Of Factor Investment Strategies?
While the S&P 500 has surged in the past year, some stocks have been left behind – and while some of those left in the… Read More »Left Behind For No Good Reason? 3 “Deeply Discounted” Stocks For Value Investors To Consider